Archer Investment Corp Biomarin Pharmaceutical Inc Transaction History
Archer Investment Corp
- $386 Billion
- Q1 2025
A detailed history of Archer Investment Corp transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Archer Investment Corp holds 70 shares of BMRN stock, worth $4,344. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70
Previous 70
-0.0%
Holding current value
$4,344
Previous $4.6 Million
7.54%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
648Shares Held
184MCall Options Held
2MPut Options Held
1.67M-
Black Rock Inc. New York, NY22.7MShares$1.41 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.18 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA17.8MShares$1.1 Billion1.06% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$915 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$806 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.5B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...